ヒスチジン銅注射液の安定性およびヒスタミン含有量の検討

DOI NDLデジタルコレクション 参考文献9件

書誌事項

タイトル別名
  • Stability of Copper Histidinate Injection and Histamine Formation in Menkes Disease

この論文をさがす

説明

Menkes disease is characterized by inhibition of the absorption and transport of dietary copper. The Okayama University Medical and Dental School uses L-histidine-copper to treat this disease and in the present study, we examined the stability of the copper histidinate injection solution used for this purpose. High-performance liquid chromatography (HPLC) performed on day 56 following injection revealed that histidine levels had dropped to 90.4%, a non-significant decrease and histamine levels were unchanged. Moreover, atomic absorption spectrophotometry revealed that copper concentrations were not significantly decreased (89.7%) between days 0 and 56. Through visual observation, we noted a gradual increase in floats from day 42 to day 56, leading us to suggest that the use of copper histidinate be limited to 1 month.<br>The above results should alleviate any concern about histamine-associated adverse effects.

収録刊行物

  • 医療薬学

    医療薬学 32 (11), 1133-1137, 2006

    一般社団法人日本医療薬学会

参考文献 (9)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ